Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

NEWS AND EVENTS

News

News for year:

  • January 25, 2010

    Theratechnologies reports that the FDA will reschedule for administrative reasons the Advisory Committee meeting to review tesamorelin’s NDA More...

  • January 18, 2010

    Theratechnologies reports date for FDA Advisory Committee Review of the Tesamorelin New Drug Application More...

  • January 11, 2010

    Theratechnologies to present at Biotech Showcase 2010 More...

 

This website contains all press releases issued by Theratechnologies between 2002 and 2009. To obtain prior press releases, please visit SEDAR’s website at: www.sedar.com.

SUBSCRIBE TO OUR EMAIL LIST

Email address
Email address confirmation

ALTERNATIVE TO THE EMAIL LIST

We invite you to subscribe to our site using a RSS feed. This technology keeps you posted on new developments announced on our website.

The RSS feed does not use your email, thus:

  • No spam
  • No viruses
  • Easy to unsubscribe

Find out more...